145
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Analysis of Drug-Resistant Tuberculosis in Children in Shenyang, China, 2017–2021

, , , , , , , , , , , & show all
Pages 6983-6998 | Received 03 Aug 2023, Accepted 19 Oct 2023, Published online: 01 Nov 2023

References

  • World Health Organization. Global Tuberculosis Report 2022. Geneva: World Health Organization; 2022.
  • World Health Organization. WHO Consolidated Guidelines on Tuberculosis Module 5: Management of Tuberculosis in Children and Adolescents. Geneva: World Health Organization; 2022.
  • World Health Organization. Guidance for National Tuberculosis Programmes on the Management of Tuberculosis in Children. 2nd ed. Geneva: World Health Organization; 2014.
  • Jenkins HE, Yuen CM. The burden of multidrug-resistant tuberculosis in children. Int J Tuberc Lung Dis. 2018;22(5):3–6. doi:10.5588/ijtld.17.0357
  • Dodd PJ, Gardiner E, Coghlan R, Seddon JA. The burden of childhood tuberculosis in 22 high-burden countries: a mathematical modelling study. Lancet Glob Health. 2014;2(8):e453–459. doi:10.1016/S2214-109X(14)70245-1
  • Seddon JA, Hesseling AC, Willemse M, et al. Culture-confirmed multidrug-resistant tuberculosis in children: clinical features, treatment, and outcome. Clin Infect Dis. 2012;54(2):157–166. doi:10.1093/cid/cir772
  • Zignol M, Sismanidis C, Falzon D, et al. Multidrug-resistant tuberculosis in children: evidence from global surveillance. Eur Respir J. 2013;42(3):701–707. doi:10.1183/09031936.00175812
  • World Health Organization. Rapid Implementation of the Xpert MTB/RIF Diagnostic Test: Technical and Operational’how-To’; Practical Considerations. Geneva: World Health Organization; 2011.
  • World Health Organization. Xpert MTB/RIF Assay for the Diagnosis of Pulmonary and Extrapulmonary TB in Adults and Children: Policy Update. Geneva: World Health Organization; 2013.
  • Helb D, Jones M, Story E, et al. Rapid detection of mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol. 2010;48(1):229–237. doi:10.1128/JCM.01463-09
  • Saeed M, Ahmad M, Iram S, Riaz S, Akhtar M, Aslam M. GeneXpert technology: a breakthrough for the diagnosis of tuberculous pericarditis and pleuritis in less than 2 hours. Saudi Med J. 2017;38(7):699–705. doi:10.15537/smj.2017.7.17694
  • Tao NN, He XC, Zhang XX, Liu Y, Yu CB, Li HC. Drug-resistant tuberculosis among children, China, 2006–2015. Emerg Infect Dis. 2017;23(11):800–1805. doi:10.3201/eid2311.170234
  • Sun L, Qi X, Liu F, et al. A test for more accurate diagnosis of pulmonary tuberculosis. Pediatrics. 2019;144(5):e20190262. doi:10.1542/peds.2019-0262
  • World Health Organization. WHO Consolidated Guidelines on Tuberculosis Module 4: Treatment-Drug-Resistant Tuberculosis Treatment. Geneva: World Health Organization; 2020.
  • World Health Organization. Pocket Book of Hospital Care for Children: Guidelines for the Management of Common Childhood Illnesses. Geneva: World Health Organization; 2013.
  • Carter BB, Zhang Y, Zou H, et al. Survival analysis of patients with tuberculosis and risk factors for multidrug-resistant tuberculosis in Monrovia, Liberia. PLoS One. 2021;16(4):e0249474. doi:10.1371/journal.pone.0249474
  • Wang T, Dong F, Li QJ, et al. Clinical and drug resistance characteristics of new pediatric tuberculosis cases in Northern China. Microb Drug Resist. 2018;24(9):1397–1403. doi:10.1089/mdr.2017.0382
  • Xu Y, Li Q, Zhu M, et al. The epidemiological characteristics and profile of drug-resistant tuberculosis among children with tuberculosis in Sichuan, China, 2015–2018: a retrospective study. Medicine. 2020;99(43):e22608. doi:10.1097/MD.0000000000022608
  • DiNardo AR, Detjen A, Ustero P, et al. Culture is an imperfect and heterogeneous reference standard in pediatric tuberculosis. Tuberculosis. 2016;101S:S105–S108. doi:10.1016/j.tube.2016.09.021
  • Chu P, Chang Y, Zhang X, et al. Epidemiology of extrapulmonary tuberculosis among pediatric inpatients in mainland China: a descriptive, multicenter study. Emerg Microbes Infect. 2022;11(1):1090–1102. doi:10.1080/22221751.2022.2054367
  • Pang Y, Wang Y, Zhao S, Liu J, Zhao Y, Li H. Evaluation of the Xpert MTB/RIF assay in gastric lavage aspirates for diagnosis of smear-negative childhood pulmonary tuberculosis. Pediatr Infect Dis J. 2014;33(10):1047–1051. doi:10.1097/INF.0000000000000403
  • Nhu NT, Ha DT, Anh ND, et al. Evaluation of Xpert MTB/RIF and MODS assay for the diagnosis of pediatric tuberculosis. BMC Infect Dis. 2013;13(1):31. doi:10.1186/1471-2334-13-31
  • Ness TE, Meiwes L, Kay A, et al. Optimizing DNA extraction from pediatric stool for diagnosis of tuberculosis and use in next-generation sequencing applications. Microbiol Spectr. 2023;11(1):e0226922. doi:10.1128/spectrum.02269-22
  • De Haas P, Nhung NV, Hng NT, et al. Introduction of the simple one-step stool Xpert ultra method to detect TB in children and adults. Int J Tuberc Lung Dis. 2023;27(1):19–27. doi:10.5588/ijtld.22.0161
  • Sun L, Liu Y, Fang M, et al. Use of Xpert MTB/RIF Ultra assay on stool and gastric aspirate samples to diagnose pulmonary tuberculosis in children in a high-tuberculosis-burden but resource-limited area of China. Int J Infect Dis. 2022;114:236–243. doi:10.1016/j.ijid.2021.11.012
  • Hart PD, Sutherland I. BCG and vole bacillus vaccines in the prevention of tuberculosis in adolescence and early adult life. Br Med J. 1977;2(6082):293–295. doi:10.1136/bmj.2.6082.293
  • Li T, Yan X, Du X, et al. Extrapulmonary tuberculosis in China: a national survey. Int J Infect Dis. 2023;128:69–77. doi:10.1016/j.ijid.2022.12.005
  • World Health Organization. Global Tuberculosis Report 2020. Geneva: World Health Organization; 2020.
  • World Health Organization. Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis: 2011 Update. Geneva: World Health Organization; 2011.
  • Zhang X, Yin J, Li H, et al. Diagnostic and treatment delays of multidrug-resistant tuberculosis before initiating treatment: a cross-sectional study. Trop Med Int Health. 2015;20(11):1431–1437. doi:10.1111/tmi.12566
  • Zhou M, Liu S, Li Q, et al. Drug resistance characteristics of Mycobacterium tuberculosis isolates between 2014 and 2017 in Sichuan, China: a retrospective study. PLoS One. 2018;13(12):e0209902. doi:10.1371/journal.pone.0209902
  • Zhou R, Zheng T, Luo D, et al. Drug resistance characteristics of Mycobacterium tuberculosis isolates obtained between 2018 and 2020 in Sichuan, China. Epidemiol Infect. 2022;150:e27. doi:10.1017/S0950268822000127
  • Wang XW, Pappoe F, Huang Y, et al. Xpert MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in children: a meta-analysis. Clin Lab. 2015;61(11/2015):1775–1785. doi:10.7754/clin.lab.2015.150509
  • Detjen AK, Dinardo AR, Leyden J, et al. Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in children: a systematic review and meta-analysis. Lancet Respir Med. 2015;3:451–461. doi:10.1016/S2213-2600(15)00095-8
  • Lavu EK, Johnson K, Banamu J, et al. Drug-resistant tuberculosis diagnosis since Xpert ® MTB/RIF introduction in Papua New Guinea, 2012–2017. Public Health Action. 2019;9(1):S12–S18. doi:10.5588/pha.19.0005
  • World Health Organization. Xpert MTB/RIF Implementation Manual: Technical and Operational ‘How-To’; Practical Considerations. Geneva: World Health Organization; 2014.
  • Tao NN, Li YF, Song WM, et al. Risk factors for drug-resistant tuberculosis, the association between comorbidity status and drug-resistant patterns: a retrospective study of previously treated pulmonary tuberculosis in Shandong, China, during 2004–2019. BMJ Open. 2021;11(6):e044349. doi:10.1136/bmjopen-2020-044349
  • Maciel EL, Brioschi AP, Peres RL, et al. Smoking and 2-month culture conversion during anti-tuberculosis treatment. Int J Tuberc Lung Dis. 2013;17(2):225–228. doi:10.5588/ijtld.12.0426
  • World Health Organization. WHO Guidelines Approved by the Guidelines Review Committee. Nutritional Care and Support for Patients with Tuberculosis. Geneva: World Health Organization; 2013.
  • Magassouba AS, Touré AA, Diallo BD, et al. Malnutrition prevalence and associated biochemical factors among drug-resistance tuberculosis (DR-TB) patients at key treatment sites in Conakry City, Republic of Guinea. Pan Afr Med J. 2021;38:279. doi:10.11604/pamj.2021.38.279.27270
  • Ullah I, Javaid A, Tahir Z, et al. Pattern of drug resistance and risk factors associated with development of drug resistant mycobacterium tuberculosis in Pakistan. PLoS One. 2016;11(1):e0147529. doi:10.1371/journal.pone.0147529
  • Mulu W, Mekonnen D, Yimer M, et al. Risk factors for multidrug resistant tuberculosis patients in Amhara National Regional State. Afr Health Sci. 2015;15(2):368–377. doi:10.4314/ahs.v15i2.9
  • World Health Organization. Roadmap Towards Ending TB in Children and Adolescents. Geneva: World Health Organization; 2018.
  • Marais BJ, Schaaf HS. Childhood tuberculosis: an emerging and previously neglected problem. Infect Dis Clin North Am. 2010;24(3):727–749. doi:10.1016/j.idc.2010.04.004
  • Kunkel A, Abel ZWP, Nathavitharana RR, et al. Smear positivity in paediatric and adult tuberculosis: systematic review and meta-analysis. BMC Infect Dis. 2016;16(1):282. doi:10.1186/s12879-016-1617-9